Summary
Martina Orlovic is a Health Economist and a PhD student at the Centre for Health Policy at the Institute of Global Health Innovation, Imperial College London.
Her research is focused on determinants of end-of-life care and dying in order to improve patients' health outcomes, and provision of end-of-life care in the USA and Europe. She is particularly interested in the use of risk-adjustments schemes and predictive modelling techniques as means to improve quality of care at the end-of-life and health system performance. Her research is supervised by Professor Elias Mossialos and Professor the Lord Ara Darzi.
Martina’s other academic interests include patient safety and outcomes, healthcare delivery and health policy.
Martina has previously served as an advisor to the World Health Organization, the Government of Qatar, and several health insurance and consultancy companies.
Prior to joining Imperial College London, Martina finished Bachelor`s and Master`s degree in Economics and Business at the University of Zagreb with 5.00/5.00 grade point average, as the only student in her class. In addition, she was awarded the Chevening Scholarship for a Master’s in International Health Policy (Health Economics) at the London School of Economics and Political Science (LSE). At LSE, she was awarded the Brian Abel-Smith Prize for best overall performance.
Publications
Journals
Orlovic M, Ahmad A, Saunders BP, 2023, Economic impact of implementing optical diagnosis with a "resect and discard" strategy within the English Bowel Cancer Screening Programme: findings from the DISCARD3 study, Gastrointestinal Endoscopy, Vol:98, ISSN:0016-5107, Pages:73-82
Magni T, Ragni C, Pelizzi N, et al., 2023, Health Economic Studies of Surfactant Replacement Therapy in Neonates with Respiratory Distress Syndrome: A Systematic Literature Review, Pharmacoeconomics-open, ISSN:2509-4262
Orlovic M, Mossialos E, Orkaby AR, et al., 2022, Challenges for Patients Dying of Heart Failure and Cancer, Circulation-heart Failure, Vol:15, ISSN:1941-3289, Pages:1069-1079
Orlovic M, Magni T, Lukyanov V, et al., 2022, Cost-effectiveness of single-inhaler extrafine beclometasone dipropionate/ formoterol fumarate/glycopyrronium in patients with uncontrolled asthma in England, Respiratory Medicine, Vol:201, ISSN:0954-6111
Conference
Colucciello A, Magni T, Ragni C, et al., 2022, A SYSTEMATIC LITERATURE REVIEW OF THE ECONOMIC BURDEN OF SURFACTANT USE IN THE TREATMENT OF NEONATES WITH RESPIRATORY DISTRESS SYNDROME, ELSEVIER SCIENCE INC, Pages:S486-S486, ISSN:1098-3015